Wedbush Securities’s Epizyme, Inc EPZM Stock Holding History

Wedbush Securities’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-43,133	Closed	-$63K	–	1125
2022 Q2	$63K	Hold	43,133	–	–	﹤0.01%	1023
2022 Q1	$50K	Hold	43,133	–	–	﹤0.01%	1074
2021 Q4	$108K	Hold	43,133	–	–	﹤0.01%	1120
2021 Q3	$221K	Hold	43,133	–	–	0.01%	1014
2021 Q2	$358K	Buy	43,133 +1,150	+3%	+$9.7K	0.02%	780
2021 Q1	$366K	Buy	+41,983	New	+$434K	0.02%	715
2020 Q4	–	Sell	-26,450	Closed	-$316K	–	1026
2020 Q3	$316K	Buy	26,450 +790	+3%	+$10.6K	0.03%	595
2020 Q2	$412K	Buy	+25,660	New	+$448K	0.04%	492

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Wedbush Securities's EPZM Position: Q3 2022 in Review

Wedbush Securities sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 43,133 shares — an estimated $63K sold.

Wedbush Securities first reported a position in EPZM in Q2 2020 and held it in 8 quarters. The position peaked at $412K in Q2 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Wedbush Securities reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Wedbush Securities sold 43,133 Epizyme, Inc shares in Q3 2022, an estimated $63K.
Wedbush Securities first reported a position in Epizyme, Inc in Q2 2020 and held it in 8 quarters.
Wedbush Securities's Epizyme, Inc position peaked at $412K in Q2 2020.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Wedbush Securities's 13F filing for Q3 2022, filed 18 Oct 2022.